RhumbLine Advisers’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20,151
| Closed | -$27.6K | – | 4207 |
|
|
2024
Q2 | $27.6K | Sell |
20,151
-42,644
| -68% | -$58.4K | ﹤0.01% | 3814 |
|
|
2024
Q1 | $216K | Buy |
62,795
+2,108
| +3% | +$7.25K | ﹤0.01% | 3144 |
|
|
2023
Q4 | $149K | Sell |
60,687
-1,665
| -3% | -$4.1K | ﹤0.01% | 3316 |
|
|
2023
Q3 | $106K | Buy |
62,352
+3,626
| +6% | +$6.16K | ﹤0.01% | 3440 |
|
|
2023
Q2 | $176K | Buy |
+58,726
| New | +$176K | ﹤0.01% | 3302 |
|
|
2022
Q2 | – | Sell |
-14,549
| Closed | -$73K | – | 3107 |
|
|
2022
Q1 | $73K | Buy |
14,549
+2,336
| +19% | +$11.7K | ﹤0.01% | 2939 |
|
|
2021
Q4 | $240K | Buy |
12,213
+886
| +8% | +$17.4K | ﹤0.01% | 2782 |
|
|
2021
Q3 | $333K | Buy |
11,327
+833
| +8% | +$24.5K | ﹤0.01% | 2723 |
|
|
2021
Q2 | $445K | Sell |
10,494
-298
| -3% | -$12.6K | ﹤0.01% | 2612 |
|
|
2021
Q1 | $549K | Buy |
+10,792
| New | +$549K | ﹤0.01% | 2447 |
|